Healthcare & Life Sciences
Amal Therapeutics
Switzerlandamaltherapeutics.com
Amal Therapeutics is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series B, 2 tracked investors.
series-b
series-b
Stage
2
Investors
About Amal Therapeutics
Amal Therapeutics is a company headquartered in Switzerland. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Amal Therapeutics is a Swiss biotechnology company developing therapeutic cancer vaccines and immunotherapies using proprietary peptide-based platforms to elicit tumor-specific T cell responses for oncology indications.
Explore Amal Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.